Search Results

Press Releases

CORRECTING and REPLACING Access Vascular Highlights New Midline Catheter Data at AVA 2024

Data Presented at the AVA Annual Scientific Meeting Shows Significantly Lower Complication and Failure Rates with Access Vascular’s HydroMID® Midline Catheter

October 2, 2024

·

2 min read

Business

QT Imaging Announces First Quarter 2024 Financial Results

QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first quarter of 2024.

May 10, 2024

·

22 min read

Business

QT Imaging Holdings’ Technology Advances Medical Imaging Research at the University of Oklahoma’s Health Stephenson Cancer Center

QT Imaging Holdings, Inc. is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment.

June 24, 2024

·

5 min read

Biotech Bay

QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell

QT Imaging Holdings, Inc., a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is proud to announce the Opening Bell Ceremony at the Nasdaq MarketSite in Times Square.

April 22, 2024

·

2 min read

Thryv Therapeutics to Present Preclinical Data of SGK1 Inhibition in Models of Drug-Induced QT Prolongation at the 2024 Heart Rhythm Society Meeting

Thryv Therapeutics Inc. today announced a poster presentation of SGK1 inhibition in models of Drug-Induced QT prolongation at the 2024 Heart Rhythm Society meeting in Boston, MA.

May 7, 2024

·

1 min read

Biotech Bay

QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership

QT Imaging Holdings, Inc. is pleased to announce the first commercial sale of a QTI Breast Acoustic CT ™ System to True Health Center for Functional Medicine.

March 7, 2024

·

4 min read

FDA

Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment

October 1, 2024

·

2 min read

Biotech Bay

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

QT Imaging Holdings, Inc. is proud to announce positive data regarding the diagnostic performance of QTI’s Breast Acoustic CT TM Scans for mass detection from its second blinded multi-reader multi-case study.

April 16, 2024

·

5 min read

Biotech Bay

QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units

QT Imaging Holdings, Inc., a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to “QTIWW”, currently trading in the over-the-counter market, effective as of March 11, 2024.

March 15, 2024

·

1 min read

Biotech Bay

QT Imaging’s Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer

QT Imaging Holdings, Inc. a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with our strategic business and distribution partner are proud to announce their partnership with the Center of New Medicine in Irvine, California.

April 11, 2024

·

5 min read